Picture of Biocon logo

BIOCON Biocon Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Momentum

Relative Strength (%)
1m+4.09%
3m-7.49%
6m-3.19%
1yr-11.57%
Volume Change (%)
10d/3m-16.06%
Price vs... (%)
52w High-14.8%
50d MA-3.23%
200d MA+1.03%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)31.58
PEG Ratio (f)1.22
EPS Growth (f)34.8%
Dividend Yield (f)0.46%
Valuation (ttm)IndustryMarket
Price to Book Value1.65
Price to Tang. Bookn/a
Price to Free Cashflown/a
Price to Sales2.14
EV to EBITDA14.96

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.25%
Return on Equity8.39%
Operating Margin12.86%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueIN₹m55,14463,00571,43181,840111,742145,799.27167,292.8422.03%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+145.75-20.42-16.87+17.08-27.17+41.44+34.8n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Biocon EPS forecast chart

Profile Summary

Biocon Limited is an India-based biopharmaceutical company, which focuses on treating diabetes, cancer and autoimmune diseases. Its segment includes Generics, Biosimilars, Novel Biologics and Research Services. It has developed and commercialized novel biologics, biosimilars, and complex small molecule active pharmaceutical ingredients (APIs) in India and several key global markets, as well as Generic Formulations in the United Sates, Europe and key emerging markets. Its API portfolio includes cardiology, anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology and other key products. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. It has over five facilities across Bangalore, Hyderabad and Visakhapatnam in India. Its API manufacturing facilities leverage complex technology platforms that range from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
November 29th, 1978
Public Since
April 17th, 2004
No. of Shareholders
421,688
No. of Employees
3,408
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
in flag iconNational Stock Exchange of India
Shares in Issue
1,196,804,982

BIOCON Share Price Performance

Upcoming Events for BIOCON

Full Year 2024 Biocon Ltd Earnings Release

Full Year 2024 Biocon Ltd Earnings Call

Q1 2025 Biocon Ltd Earnings Release

Biocon Ltd Annual Shareholders Meeting

Similar to BIOCON

Picture of Suven Life Sciences logo

Suven Life Sciences

in flag iconNational Stock Exchange of India

Picture of Syngene International logo

Syngene International

in flag iconNational Stock Exchange of India

Picture of Take Solutions logo

Take Solutions

in flag iconNational Stock Exchange of India

Picture of Vimta Labs logo

Vimta Labs

in flag iconNational Stock Exchange of India

FAQ